The MiR-532-E2F1 Feedback Loop Contributes to Gastric Cancer Progression

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2022 Apr 20

PMID 35440106

Authors

Shanting Gao

Xiaomin Bu

Yongyue Gao

Zengtao Bao

Wenchao Shi

Lipeng Luan

Huiyu Chen

Baoming Zhang

Qingshui Tian

Wenxian Guan

Liuqing Yang

Affiliations

Soon will be listed here.

Abstract

Gastric cancer (GC) ranks fourth in incidence and mortality worldwide, ascertaining the pathogenesis of GC is crucial for its treatment. E2F1, which regulates the transcription of genes encoding proteins involved in DNA repair, DNA replication, mitosis and survival of cancer patients, functions as a key regulator in GC progression. However, the underneath mechanism of these processes is not fully elucidated. Here, TCGA database analysis, microarray immunohistochemical technique and western blot showed that E2F1 was highly upregulated in clinical GC tissues and correlated with tumor malignancy. In vitro and in vivo assays confirmed the oncogenic function of E2F1. MiR-532 was decreased and negatively correlated with E2F1 in GC tissues. MiR-532 directly targeted and inhibited E2F1 expression, leading to the decrease of ASK1 and elevation of TXNIP, and affected proliferation, cell cycle, apoptosis and DNA damage in vitro and tumor growth in vivo. Moreover, E2F1 serves as a transcriptional repressor to suppress miR-532 expression and a double-negative feedback loop was formed between them. This study demonstrates the significant roles of the E2F1-miR-532 double-negative feedback loop in GC progression and may represent a potential target for GC therapy.

Citing Articles

Biochemical analysis of miR-217 and miR-532 in patients with fibromyalgia.

Ayoub S, Ahmed A, Abdelwahed M, Khalefa A, Awaji A, Zekry S Eur J Med Res. 2025; 30(1):85.

PMID: 39920875 PMC: 11803959. DOI: 10.1186/s40001-025-02330-y.

E2F1 and E2F7 regulate gastric cancer cell proliferation, respectively, through transcriptional activation and transcriptional repression of MYBL2.

Wu T, Jiang F, Wu F, Zheng G, Li Y, Wu L J Biol Chem. 2024; 301(1):108027.

PMID: 39613162 PMC: 11731210. DOI: 10.1016/j.jbc.2024.108027.

Circulating miR-18a and miR-532 Levels in Extrahepatic Cholangiocarcinoma.

Orzan R, Tigu A, Nechita V, Nistor M, Agoston R, Gonciar D J Clin Med. 2024; 13(20).

PMID: 39458127 PMC: 11509052. DOI: 10.3390/jcm13206177.

The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy.

Pathania A, Chava H, Balusu R, Pasupulati A, Coulter D, Challagundla K Mol Ther Oncol. 2024; 32(2):200785.

PMID: 38595981 PMC: 10973673. DOI: 10.1016/j.omton.2024.200785.

Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors.

Liao B, Wang J, Yuan Y, Luo H, Ouyang X Cancer Cell Int. 2024; 24(1):122.

PMID: 38555465 PMC: 10981830. DOI: 10.1186/s12935-024-03285-6.

References

Kent L, Bae S, Tsai S, Tang X, Srivastava A, Koivisto C . Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma. J Clin Invest. 2017; 127(3):830-842. PMC: 5330731. DOI: 10.1172/JCI87583. View

Ding M, Lu X, Wang C, Zhao Q, Ge J, Xia Q . The E2F1-miR-520/372/373-SPOP Axis Modulates Progression of Renal Carcinoma. Cancer Res. 2018; 78(24):6771-6784. DOI: 10.1158/0008-5472.CAN-18-1662. View

Wu L, Timmers C, Maiti B, Saavedra H, Sang L, Chong G . The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 2001; 414(6862):457-62. DOI: 10.1038/35106593. View

Paul A, Wang B . RNF8- and Ube2S-Dependent Ubiquitin Lysine 11-Linkage Modification in Response to DNA Damage. Mol Cell. 2017; 66(4):458-472.e5. PMC: 5642944. DOI: 10.1016/j.molcel.2017.04.013. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Kloosterman W, Plasterk R . The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006; 11(4):441-50. DOI: 10.1016/j.devcel.2006.09.009. View

Tarangelo A, Lo N, Teng R, Kim E, Le L, Watson D . Recruitment of Pontin/Reptin by E2f1 amplifies E2f transcriptional response during cancer progression. Nat Commun. 2015; 6:10028. PMC: 4686657. DOI: 10.1038/ncomms10028. View

Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young R . E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 2002; 16(2):245-56. PMC: 155321. DOI: 10.1101/gad.949802. View

Fang Z, Gong C, Yu S, Zhou W, Hassan W, Li H . NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling. Cancer Lett. 2017; 415:58-72. DOI: 10.1016/j.canlet.2017.11.040. View

10.

Bartel D . MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2):215-33. PMC: 3794896. DOI: 10.1016/j.cell.2009.01.002. View

11.

Doil C, Mailand N, Bekker-Jensen S, Menard P, Larsen D, Pepperkok R . RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell. 2009; 136(3):435-46. DOI: 10.1016/j.cell.2008.12.041. View

12.

Wong N, Chen Y, Chen S, Wang X . OncomiR: an online resource for exploring pan-cancer microRNA dysregulation. Bioinformatics. 2017; 34(4):713-715. PMC: 5860608. DOI: 10.1093/bioinformatics/btx627. View

13.

Rodriguez-Bravo V, Pippa R, Song W, Carceles-Cordon M, Dominguez-Andres A, Fujiwara N . Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import. Cell. 2018; 174(5):1200-1215.e20. PMC: 6150493. DOI: 10.1016/j.cell.2018.07.015. View

14.

Dweep H, Sticht C, Pandey P, Gretz N . miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform. 2011; 44(5):839-47. DOI: 10.1016/j.jbi.2011.05.002. View

15.

Ren J, Ding L, Zhang D, Shi G, Xu Q, Shen S . Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Theranostics. 2018; 8(14):3932-3948. PMC: 6071523. DOI: 10.7150/thno.25541. View

16.

Schmittgen T, Jiang J, Liu Q, Yang L . A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res. 2004; 32(4):e43. PMC: 390315. DOI: 10.1093/nar/gnh040. View

17.

Petrocca F, Visone R, Onelli M, Shah M, Nicoloso M, De Martino I . E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 2008; 13(3):272-86. DOI: 10.1016/j.ccr.2008.02.013. View

18.

Chen G, Magis A, Xu K, Park D, Yu D, Owonikoko T . Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy. J Clin Invest. 2017; 128(1):500-516. PMC: 5749500. DOI: 10.1172/JCI92742. View

19.

Xiang S, Wang Z, Ye Y, Zhang F, Li H, Yang Y . E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer. Oncogene. 2018; 38(8):1269-1281. DOI: 10.1038/s41388-018-0494-7. View

20.

Lee J, Leem S, Lee S, Kim S, Park E, Kim S . Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J Clin Oncol. 2010; 28(16):2660-7. DOI: 10.1200/JCO.2009.25.0977. View